UK HealthTech firm granted 'key' US patent
Digital healthcare firm, and developer of a new patient monitoring platform Isansys Lifecare has announced that a key method patent has been granted by the US Patent Office.
Its technology, which enables the early detection of deterioration in patients, integrating sensors, connectivity and predictive analytics.
Its patent relates to the wireless wearable sensor technology incorporated in the Patient Status Engine (PSE).
The patent will protects the construction and methods used by the firm to recycle its Lifetouch and Lifetemp wireless body-worn sensors which are used by clinicians and nurses to automatically collect and analyse their patients’ vital signs in real-time.
“The granting of this patent is critically important and further strengthens our patient monitoring platform as it covers a key method for reducing the costs of the devices, making them universally affordable,” said Keith Errey, CEO of Isansys.
“Other large scale in-patient wireless monitoring projects have failed because the technology has been too expensive.
“With this patent we can now realize our ambition of building new and comprehensive physiological data sets through the provision of accurate, wireless wearable sensor monitoring for patients in all countries and in all healthcare facilities, including hospital-at-home applications.
“Most importantly however, we are protecting the environment and reducing costs for patients and providers.”